Study of Sasanlimab (PF-06801591) in Combination With Bacillus Calmette-Guerin (BCG) in Participants With High-Risk Non-Muscle Invasive Bladder Cancer (CREST)

Investigator: Raj Satkunasivam, MD

Study Coordinator: Taliah Muhammad

Status: Enrolling

ClinicalTrials.gov Number: NCT04165317

Phone: 281.753.4803

Protocol Number: PRO00024845

Description

Primary Purpose: Treatment
More to Explore